Suchergebnisse - "Fanale, Daniele"

PubPharm (100)

1

Clinical relevance of exosome-derived microRNAs in Ovarian Cancer : Looking for new tumor biological fingerprints

enthalten in: Critical reviews in oncology/hematology | 2024

von Fanale, D. | Corsini, L. | Bono, M. | +18

2

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors : Still looking through a dirty glass window?

enthalten in: Cancer treatment reviews | 2023

von Incorvaia, L. | Perez, A. | Marchetti, C. | +21

3

Potential agnostic role of BRCA alterations in patients with several solid tumors : One for all, all for one?

enthalten in: Critical reviews in oncology/hematology | 2023

von Fanale, D. | Corsini, L. | Pedone, E. | +11

4

Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer

enthalten in: BMC cancer | 2023

von Fanale, D. | Brando, C. | Corsini, L. | +18

5

Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab : finding the missing links in the symbiotic immune-metabolic interplay

enthalten in: Therapeutic advances in medical oncology | 2023

von Incorvaia, L. | Rinaldi, G. | Badalamenti, G. | +17

6

Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer

enthalten in: Cancers | 2022

von Fanale, D. | Dimino, A. | Pedone, E. | +10

7

BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome : Looking for the hidden meaning

enthalten in: Critical reviews in oncology/hematology | 2022

von Fanale, D. | Pivetti, A. | Cancelliere, D. | +13

8

MUTYH-associated tumor syndrome : The other face of MAP

enthalten in: Oncogene | 2022

von Magrin, L. | Fanale, D. | Brando, C. | +10

9

Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?

enthalten in: Critical reviews in oncology/hematology | 2022

von Fanale, D. | Corsini, L. | Scalia, R. | +15

10

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

enthalten in: Frontiers in oncology | 2022

von Fanale, D. | Corsini, L. | Brando, C. | +15

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]